EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)

Satya Siva Kishan Yalamarty iD, Nina Filipczak iD, Xiang Li iD, Md Abdus Subhan iD, Farzana Parveen iD, Janaína Artem Ataide iD, Bharat Ashok Rajmalani, Vladimir P Torchilin

Cancers · 01.04.2023 · 15 (7) · 2116

DOI: 10.3390/cancers15072116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 01.04.2023. Verfasst von Satya Siva Kishan Yalamarty und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pharmaceutical Biotechnology and Nanomedicine (CPBN), Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, US…. Die Arbeit wurde bisher 299-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer that is difficult to treat due to its resistance to both radiation and chemotherapy. This resistance is largely due to the unique biology of GBM cells, which can evade the effects of conventional treatments through mechanisms such as increased resistance to cell death and rapid regeneration of cancerous cells. Additionally, the blood–brain barrier makes it difficult for chemotherapy drugs to reach GBM cells, leading to reduced effectiveness. Despite these challenges, there are several treatment options available for GBM. The standard of care for newly diagnosed GBM patients involves surgical resection followed by concurrent chemoradiotherapy and adjuvant chemotherapy. Emerging treatments include immunotherapy, such as checkpoint inhibitors, and targeted therapies, such as bevacizumab, that attempt to attack specific vulnerabilities in GBM cells. Another promising approach is the use of tumor-treating fields, a type of electric field therapy that has been shown to slow the growth of GBM cells. Clinical trials are ongoing to evaluate the safety and efficacy of these and other innovative treatments for GBM, intending to improve with outcomes for patients.

Schlagwörter

Stichwörter der Autor:innen

drug delivery systemsglioblastoma multiformeimmunotherapynanomedicineresistance

Autor:innen und Institutionen

  • Center for Pharmaceutical Biotechnology and Nanomedicine (CPBN), Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
  • State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Chinese Medicine, Nanchang 330006, China.
  • Department of Chemistry, ShahJalal University of Science and Technology, Sylhet 3114, Bangladesh.
  • Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan.
  • Department of Pharmacy Services, DHQ Hospital, Jhang 35200, Pakistan.
  • Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas 13083-871, Brazil.

ORCID-Profile: Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, Md Abdus Subhan, Farzana Parveen, Janaína Artem Ataide

Zitieren

APA

Yalamarty, S. S. K., Filipczak, N., Li, X., Subhan, M. A., Parveen, F., Ataide, J. A., Rajmalani, B. A., & Torchilin, V. P. (2023). Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). Cancers, 15(7), 2116. https://doi.org/10.3390/cancers15072116

Vancouver

Yalamarty SSK, Filipczak N, Li X, Subhan MA, Parveen F, Ataide JA, et al. Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). Cancers. 2023;15(7):2116. doi:10.3390/cancers15072116

BibTeX
@article{Yalamarty2023,
  author = {Yalamarty, Satya Siva Kishan and Filipczak, Nina and Li, Xiang and Subhan, Md Abdus and Parveen, Farzana and Ataide, Janaína Artem and Rajmalani, Bharat Ashok and Torchilin, Vladimir P},
  title = {Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {2116},
  doi = {10.3390/cancers15072116}
}
Kostenlos starten →